It is tempting to speculate that any cancer promoting advantage brought by Kindlin-3 germline inactivation may be counterbalanced by the associated defects in tumor promoting thrombosis [45] and inflammation [46] caused by these mutations. Here, FERMT3 is linked to cancer.